Tumor characteristics of dissociated response to immune checkpoint inhibition in advanced melanoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Tumor characteristics of dissociated response to immune checkpoint inhibition in advanced melanoma ; volume:73 ; number:2 ; day:27 ; month:1 ; year:2024 ; pages:1-10 ; date:2.2024
Cancer immunology immunotherapy ; 73, Heft 2 (27.1.2024), 1-10, 2.2024
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Versluis, J. M.
Hoefsmit, E. P.
Shehwana, H.
Dimitriadis, P.
Sanders, J.
Broeks, A.
Blank, C. U.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00262-023-03581-6
- URN
-
urn:nbn:de:101:1-2404291311478.339652320004
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Versluis, J. M.
- Hoefsmit, E. P.
- Shehwana, H.
- Dimitriadis, P.
- Sanders, J.
- Broeks, A.
- Blank, C. U.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Tumour-informed liquid biopsies to monitor advanced melanoma patients under immune checkpoint inhibition
Predictors of responses to immune checkpoint blockade in advanced melanoma
Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma
Neurosarcoidosis following Immune Checkpoint Inhibition
DNA methylation-based prediction of response to immune checkpoint inhibition in metastatic melanoma
DNA methylation-based prediction of response to immune checkpoint inhibition in metastatic melanoma
Total serum N-glycans associate with response to immune checkpoint inhibition therapy and survival in patients with advanced melanoma
Cryoablation and post-progression immune checkpoint inhibition in metastatic melanoma: a phase II trial
Checkpoint inhibition immunotherapy for advanced local and systemic conjunctival melanoma: a clinical case series
Cost-effectiveness of immune checkpoint inhibition and targeted treatment in combination as adjuvant treatment of patient with BRAF-mutant advanced melanoma
Evaluating immune checkpoint inhibition in colorectal cancer
Seronegative autoimmune autonomic ganglionopathy from dual immune checkpoint inhibition in a patient with metastatic melanoma
Tumour-informed liquid biopsies to monitor advanced melanoma patients under immune checkpoint inhibition
Predictors of responses to immune checkpoint blockade in advanced melanoma
Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma
Neurosarcoidosis following Immune Checkpoint Inhibition
DNA methylation-based prediction of response to immune checkpoint inhibition in metastatic melanoma
DNA methylation-based prediction of response to immune checkpoint inhibition in metastatic melanoma
Total serum N-glycans associate with response to immune checkpoint inhibition therapy and survival in patients with advanced melanoma
Cryoablation and post-progression immune checkpoint inhibition in metastatic melanoma: a phase II trial
Checkpoint inhibition immunotherapy for advanced local and systemic conjunctival melanoma: a clinical case series
Cost-effectiveness of immune checkpoint inhibition and targeted treatment in combination as adjuvant treatment of patient with BRAF-mutant advanced melanoma
Evaluating immune checkpoint inhibition in colorectal cancer
Seronegative autoimmune autonomic ganglionopathy from dual immune checkpoint inhibition in a patient with metastatic melanoma
Tumour-informed liquid biopsies to monitor advanced melanoma patients under immune checkpoint inhibition
Predictors of responses to immune checkpoint blockade in advanced melanoma
Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma
Neurosarcoidosis following Immune Checkpoint Inhibition
DNA methylation-based prediction of response to immune checkpoint inhibition in metastatic melanoma
DNA methylation-based prediction of response to immune checkpoint inhibition in metastatic melanoma
Total serum N-glycans associate with response to immune checkpoint inhibition therapy and survival in patients with advanced melanoma
Cryoablation and post-progression immune checkpoint inhibition in metastatic melanoma: a phase II trial
Checkpoint inhibition immunotherapy for advanced local and systemic conjunctival melanoma: a clinical case series
Cost-effectiveness of immune checkpoint inhibition and targeted treatment in combination as adjuvant treatment of patient with BRAF-mutant advanced melanoma
Evaluating immune checkpoint inhibition in colorectal cancer